Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54.8M
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
29.5M
-
Shares change
-
-37.7K
-
Total reported value, excl. options
-
$456M
-
Value change
-
+$2.08M
-
Put/Call ratio
-
0.68
-
Number of buys
-
69
-
Number of sells
-
-78
-
Price
-
$15.45
Significant Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q3 2021
206 filings reported holding CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2021.
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.5M shares
of 54.8M outstanding shares and own 53.92% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.11M shares), VANGUARD GROUP INC (3.01M shares), FARALLON CAPITAL MANAGEMENT LLC (2M shares), DISCIPLINED GROWTH INVESTORS INC /MN (1.67M shares), STATE STREET CORP (1.5M shares), Chescapmanager LLC (1.3M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.04M shares), JACOBS LEVY EQUITY MANAGEMENT, INC (891K shares), GEODE CAPITAL MANAGEMENT, LLC (837K shares), and KINGDON CAPITAL MANAGEMENT, L.L.C. (716K shares).
This table shows the top 161 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.